Skip to content

Assessment of Memory in Children With Kabuki Syndrom

Study on the Mnemic Functioning of Children With Kabuki Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03547609
Acronym
MEM-K
Enrollment
25
Registered
2018-06-06
Start date
2018-06-08
Completion date
2018-09-07
Last updated
2018-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kabuki Syndrome

Keywords

Kabuki Syndrome, Intellectual Profile, Memory

Brief summary

Mnesic function has not, at present, been evaluated in patients with Kabuki Syndrome. Some data from the neuroimagery suggest an impairment of memory function. The objective of our study is to assess the mnesic function of children with Kabuki Syndrom.

Detailed description

Kabuki Syndrome (SK - OMIM 147920 and 300867 ORPHA: 2322) is a rare genetic disease with a prevalence of approximately 1/32 000 and responsible for a malformation syndrome with mild to moderate intellectual impairment. SK is due to mutations in the KMT2D and KDM6A genes. As part of a national PHRC (AOM 07-090, clinicaltrial NCT01314534, The investigators were able to perform psychometric tests type WISC4 and MRI type VBM). Disability in SK is characterized by a heterogeneous cognitive profile with strengths and weaknesses when calculating IQ. Brain MRI reveals small hippocampi compared to controls. These 2 data are partly contradictory because the strengths of the patients with SK are a working memory and a verbal comprehension index high compared to the other indices of the tests WISC-IV. The objective of the research is to better understand the mnesic function of children with SK. 25 children aged 6 to 16 will be recruited. The diagnosis of SK will have been authenticated by the demonstration of a mutation in the KMT2D or KDM6A gene. The memory assessments will be conducted in one visit for each child, who will perform a memory assessment with a neuropsychologist, using the CMS scale.

Interventions

OTHERNo arm intervention

No arm intervention

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Child from 6 to 16 years old * Presents an already established diagnosis of Kabuki syndrome. * Free, informed and written consent signed by the participant's parents, and the investigator (at the latest inclusion day and before any research required by the research).

Exclusion criteria

* Be under 6 years old or over 16 years old * Do not master the French language * Not having access to language * Deafness not paired * Blindness.

Design outcomes

Primary

MeasureTime frameDescription
CMS (selective motor control scale) main score1 hourCMS main score

Secondary

MeasureTime frameDescription
CMS (selective motor control scale) indexes1 hourCMS indexes

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026